Restoring Lives
One Story At A Time

We are Assertio — an assertive, energetic, and empathetic pharmaceutical company built around the mission of advancing patient care. Formerly known as Depomed, we have transformed our company with a current focus on three FDA-approved products in our core areas of neurology, orphan, and specialty medicines, as we continue to identify, license, and develop new products that offer enhanced options for patients who may be underserved by existing therapies. More

In the News

August 8, 2018

Depomed Announces Second-Quarter 2018 Financial ResultsRead More

July 9, 2018

Depomed to Report Second-Quarter 2018 Financial Results on Wednesday, August 8, 2018Read More

July 6, 2018

Depomed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Read More

More News